Current:Home > InvestFDA panel overwhelmingly votes against experimental ALS treatment pushed by patients-Angel Dreamer Wealth Society D1 Reviews & Insights
FDA panel overwhelmingly votes against experimental ALS treatment pushed by patients
View Date:2024-12-23 23:03:38
Federal health advisers voted overwhelmingly against an experimental treatment for Lou Gehrig's disease at a Wednesday meeting prompted by years of patient efforts seeking access to the unproven therapy.
The panel of Food and Drug Administration experts voted 17-1 that drugmaker Brainstorm's stem cell-based treatment has not been shown effective for patients with the fatal, muscle-wasting disease known as ALS, or amyotrophic lateral sclerosis. One panel member abstained from voting.
While the FDA is not bound by the vote, it largely aligns with the agency's own strikingly negative review released earlier this week, in which staff scientists described Brainstorm's application as "scientifically incomplete" and "grossly deficient."
What were the FDA panel's objections to the treatment?
"Creating false hope can be considered a moral injury and the use of statistical magic or manipulation to provide false hope is problematic," said Lisa Lee, a bioethics and research integrity expert from Virginia Tech, who voted against the treatment. The lone positive vote came from a panel member representing patients.
Wednesday's public meeting was essentially a longshot attempt by Brainstorm and the ALS community to sway FDA's thinking on the treatment, dubbed NurOwn.
Brainstorm's single 200-patient study failed to show that NurOwn extended life, slowed disease or improved patient mobility. But FDA agreed to convene the panel of outside advisers after ALS patients and advocates submitted a 30,000-signature petition seeking a public meeting.
In the last year, the FDA has approved two new drugs for ALS, after a nearly 20-year drought of new options. The approvals followed intense lobbying by advocacy groups.
FDA leaders have recently emphasized a new level of "regulatory flexibility" when reviewing experimental treatments for fatal, hard-to-treat conditions, including ALS, Alzheimer's and muscular dystrophy.
But the agency appears unwilling to overlook the failed study results and missing information in Brainstorm's submission, including key details on manufacturing and quality control needed to establish the product's safety.
"It really is a disease that needs a safe and effective treatment and there are a lot of other prospects out there that we need to encourage. Approving one like this would get in the way of that," said Dr. Kenneth Fischbeck of the National Institutes of Health.
What do ALS patients say about the treatment?
More than a dozen people spoke during a public comment session Wednesday, including ALS patients, their family members and physicians who implored FDA to grant approval. Several speakers presented before-and-after videos showing patients who participated in Brainstorm's study walking, climbing stairs and performing other tasks that they attributed to NurOwn.
"When Matt is on Nurown it helps him, when he's off of it he gets worse," said Mitze Klingenberg, speaking on behalf of her son, Matt Klingenberg, who was diagnosed with ALS in 2018.
The FDA is expected to issue a decision on the therapy by Dec. 8.
Israel-based Brainstorm Cell Therapeutics' stock price has lost more than 90% of its value over the last year, falling to 39 cents per share before being halted ahead of Wednesday's FDA meeting.
What is ALS?
ALS destroys nerve cells in the brain and spinal cord needed to walk, talk, swallow and — eventually — breathe. Most people die within three to five years of their first symptoms.
"ALS may be considered a rare disease, but it's actually more common than people think, affecting 1 in 300 Americans. It can strike anyone at any time and is always fatal," Brian Frederick, senior vice president of communication at the ALS Association, told CBS News.
More than 30,000 people in the United States are believed to be living with ALS, and an average of 5,000 people nationwide are diagnosed with ALS each year, according to the Centers for Disease Control and Prevention.
It is also known as Lou Gehrig's disease, named for the legendary New York Yankees player who was stricken with it in the late 1930s.
- In:
- Health
- Lou Gehrig's Disease
- ALS
veryGood! (1494)
Related
- John Krasinski named People's Sexiest Man Alive for 2024
- Salma Hayek Says Her Heart Is Bursting With Love for Daughter Valentina on Her 16th Birthday
- Several Trump allies could be witnesses in Georgia election interference trial
- Medicaid coverage restored to about a half-million people after computer errors in many states
- Georgia House Republicans stick with leadership team for the next two years
- 'Paw-sitively exciting': Ohio zoo welcomes twin Siberian tiger cubs
- Louisville police credit Cardinals players for help in rescue of overturned car near their stadium
- The former head of a Florida domestic abuse agency has been charged with fraud and grand theft
- Bluesky has added 1 million users since the US election as people seek alternatives to X
- `Mama can still play': Julie Ertz leaves USWNT on her terms, leaves lasting impact on game
Ranking
- What Just Happened to the Idea of Progress?
- How Dancing with the Stars Season 32 Will Honor Late Judge Len Goodman
- Indictment alleges man threatened mass shooting at Stanley Cup game in Las Vegas
- Azerbaijan launches military operation targeting Armenian positions; 2 civilians reportedly killed, including child
- Multi-State Offshore Wind Pact Weakened After Connecticut Sits Out First Selection
- Sacramento prosecutor sues city over failure to clean up homeless encampments
- Azerbaijan launches military operation targeting Armenian positions; 2 civilians reportedly killed, including child
- Good American's Rare Friends & Family Sale Is Here: Don't Miss Up to 80% Off on All Things Denim and More
Recommendation
-
Pie, meet donuts: Krispy Kreme releases Thanksgiving pie flavor ahead of holidays
-
Police suggested charging a child for her explicit photos. Experts say the practice is common
-
Chicago Bears defensive coordinator Alan Williams resigns, citing need to address health
-
Joe Jonas Breaks Silence on Sophie Turner's Misleading Lawsuit Over Their 2 Kids
-
Indiana in the top five of the College Football Playoff rankings? You've got to be kidding
-
Over 200 people are homeless after Tucson recovery community closes during Medicaid probe
-
Justin Trudeau accuses India of credible link to activist's assassination in Canada
-
Man who sold black rhino and white rhino horns to confidential source sentenced to 18 months in U.S. prison